How much can the Portfolio diet actually lower your LDL cholesterol?
In the most direct comparison available—a randomized crossover trial where 34 people with high LDL tried all three treatments—the Portfolio diet cut LDL by 29.6% after one month, while the same diet plus 20 mg of lovastatin (a first-generation statin) cut it by 33.3% [5]. That 3.7 percentage-point gap was statistically significant, meaning statins were slightly better on average, but the diet still achieved a very large drop. Importantly, 9 out of 34 participants (26%) actually got their lowest LDL on the diet, not the statin [5]. For context, a standard low-saturated-fat control diet in that same study only lowered LDL by 8.5% [5].
These results are backed by a much larger analysis of over 210,000 people followed for up to 30 years: those who most closely followed the Portfolio diet had a 14% lower risk of heart disease, stroke, and other cardiovascular events compared to those who followed it least [2]. The same study also found that higher adherence was linked to better blood lipid and inflammation profiles [2]. So the LDL drop seen in the short-term trial translates into real-world protection over decades.
How does it compare to a statin in practice?
The key finding from the direct trial is that the Portfolio diet and a first-generation statin were not statistically different in their ability to get people below the 3.4 mmol/L LDL cutoff used for primary prevention [5]. That means for someone without existing heart disease who wants to lower their cholesterol, the diet is a genuinely viable alternative to a low-dose statin—not just a weak adjunct. However, the trial used 20 mg of lovastatin, which is a moderate dose; modern high-intensity statins (like atorvastatin 40-80 mg) typically lower LDL by 40-55%, so the diet would not match those.
It is also worth noting that the Portfolio diet is not a simple tweak—it requires eating specific amounts of plant sterols (1.0 g per 1000 calories), soy protein (21.4 g/1000 kcal), almonds (14 g/1000 kcal), and viscous fiber from oats, barley, psyllium, okra, and eggplant (10 g/1000 kcal) [5]. That is a lot of specialized food. A more recent study in young adults found that even modest adherence (a 1-point higher diet score) was linked to small but meaningful LDL reductions of about 0.009 mmol/L per point, and that 50% adherence could delay the onset of rising cardiovascular risk by an estimated 6 years [3]. So every bit helps, but the full effect requires real commitment.
Does it do anything else for heart health beyond lowering LDL?
Yes. The same young-adult study found that higher Portfolio diet scores were also linked to lower blood pressure (systolic down 0.15 mmHg per point, diastolic down 0.13 mmHg per point), lower triglycerides, lower BMI, and smaller waist circumference [3]. These are all independent risk factors for heart disease. The large cohort study confirmed that the diet was associated with a more favorable blood lipid and inflammatory profile overall [2].
The metabolomics analysis from two feeding trials showed that the diet changed over 50 different metabolites in a consistent direction, including reductions in certain cholesteryl esters and increases in compounds like N2-acetylornithine and L-pipecolic acid that reflect the plant-based, low-saturated-fat nature of the diet [1]. These metabolic shifts likely explain some of the broader benefits beyond just LDL.
About These Sources
This answer is built on 5 peer-reviewed studies — published from 2005 to 2025, 2 from 2024 or later, 3 in Q1 journals, collectively cited 66 times — selected as the most relevant from 5 studies that passed quality screening, drawn from 52 papers retrieved from a database of over 500 million.
Sources used in this answer
Metabolomic profiling of a cholesterol lowering plant-based diet from two randomized controlled feeding trials
In two small randomized controlled feeding trials (34 and 25 adults with high LDL), the Portfolio diet changed 52 metabolites consistently, including reductions in cholesteryl esters and increases in plant-based markers, reflecting its cholesterol-lowering effects [1].
Portfolio Diet Score and Risk of Cardiovascular Disease: Findings From 3 Prospective Cohort Studies
In the largest and longest study here, following over 210,000 people for up to 30 years, higher adherence to the Portfolio diet was associated with a 14% lower risk of cardiovascular disease, coronary heart disease, and stroke, plus better blood lipid and inflammatory profiles [2].
Portfolio diet and LDL-C in a young, multiethnic cohort: cross-sectional analyses with cumulative exposure modeling
In a cross-sectional study of 1,507 young adults (mean age 23), a 1-point higher Portfolio diet score was linked to lower LDL, non-HDL cholesterol, blood pressure, and body weight; modeling suggested 50% adherence could delay rising cardiovascular risk by 6 years [3].
Development of a Portfolio Diet Score and Its Concurrent and Predictive Validity Assessed by a Food Frequency Questionnaire
In a 6-month randomized trial of 652 overweight adults, a 1-point increase in the Portfolio diet score was associated with a 0.01 mmol/L reduction in LDL cholesterol, confirming the diet's predictive validity for cholesterol lowering [4].
Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants.
In a direct randomized crossover trial of 34 hyperlipidemic adults, the Portfolio diet lowered LDL by 29.6% after 4 weeks, compared to 33.3% with 20 mg lovastatin; 26% of participants achieved their lowest LDL on the diet, and the two treatments did not differ significantly in reaching the primary prevention LDL target of 3.4 mmol/L [5].